Comparative efficacy of neoadjuvant therapy in the combined treatment of bladder cancer after open and transurethral resection
DOI:
https://doi.org/10.14739/2310-1210.2013.1.15443Keywords:
superficial bladder cancer, open and transurethral resection, combined treatmentAbstract
There are represented results of the use of different modes of neoadjuvantchemoradiation impact in the combined treatment of bladder cancer Ta-T2a stages after open and transurethral resection. The most effective was the scheme including endolymphaticpolychemotherapy which allowed in the performance of transurethral resection statistically significantly achieve 5-year survival rate and life expectancy 96,3±3,63% and 4,98±0,02 respectively.
Downloads
How to Cite
1.
Dumansky YV, Maltsev OV. Comparative efficacy of neoadjuvant therapy in the combined treatment of bladder cancer after open and transurethral resection. Zaporozhye Medical Journal [Internet]. 2013Jul.12 [cited 2024Dec.23];15(1). Available from: http://zmj.zsmu.edu.ua/article/view/15443
Issue
Section
Original research
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
